Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010) : a randomised controlled trial

Thumbnail Image
Files
Pembrolizumab versus docetaxel for previously treated.pdf(3.77 KB)
Date
2016
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
Description
Keywords
Citation
URI
https://doi.org/10.1016/S0140-6736(15)01281-7
 https://repositorio.uc.cl/handle/11534/58313
Collections
Artículos de revistas